Skip to main content
Advertisement

Main menu

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET

User menu

  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Pharmacology and Experimental Therapeutics
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET
  • My alerts
  • Log in
  • My Cart
Journal of Pharmacology and Experimental Therapeutics

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Visit jpet on Facebook
  • Follow jpet on Twitter
  • Follow jpet on LinkedIn
Research ArticleBehavioral Pharmacology

Effects of Repeated Ropinirole Treatment on Phencyclidine-Induced Hyperlocomotion, Prepulse Inhibition Deficits, and Social Avoidance in Rats

Amanda M. Maple, Tanessa Call, Phylicia C. Kimmel and Ronald P. Hammer Jr.
Journal of Pharmacology and Experimental Therapeutics April 2017, 361 (1) 109-114; DOI: https://doi.org/10.1124/jpet.116.238634
Amanda M. Maple
Department of Basic Medical Sciences (A.M.M., P.C.K., R.P.H.), and Departments of Pharmacology and Psychiatry (R.P.H.), University of Arizona College of Medicine, Phoenix; and Department of Psychology (A.M.M., P.C.K., R.P.H.) and Interdisciplinary Graduate Program in Neuroscience (T.C., R.P.H.), Arizona State University, Tempe, Arizona
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Tanessa Call
Department of Basic Medical Sciences (A.M.M., P.C.K., R.P.H.), and Departments of Pharmacology and Psychiatry (R.P.H.), University of Arizona College of Medicine, Phoenix; and Department of Psychology (A.M.M., P.C.K., R.P.H.) and Interdisciplinary Graduate Program in Neuroscience (T.C., R.P.H.), Arizona State University, Tempe, Arizona
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Phylicia C. Kimmel
Department of Basic Medical Sciences (A.M.M., P.C.K., R.P.H.), and Departments of Pharmacology and Psychiatry (R.P.H.), University of Arizona College of Medicine, Phoenix; and Department of Psychology (A.M.M., P.C.K., R.P.H.) and Interdisciplinary Graduate Program in Neuroscience (T.C., R.P.H.), Arizona State University, Tempe, Arizona
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Ronald P. Hammer Jr.
Department of Basic Medical Sciences (A.M.M., P.C.K., R.P.H.), and Departments of Pharmacology and Psychiatry (R.P.H.), University of Arizona College of Medicine, Phoenix; and Department of Psychology (A.M.M., P.C.K., R.P.H.) and Interdisciplinary Graduate Program in Neuroscience (T.C., R.P.H.), Arizona State University, Tempe, Arizona
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
  • eLetters
  • PDF
Loading

Article Information

vol. 361 no. 1 109-114
DOI 
https://doi.org/10.1124/jpet.116.238634
PubMed 
28167638

Published By 
American Society for Pharmacology and Experimental Therapeutics
Print ISSN 
0022-3565
Online ISSN 
1521-0103
History 
  • Received October 28, 2016
  • Accepted January 31, 2017
  • Published online March 6, 2017.

Article Versions

  • Earlier version (February 6, 2017 - 09:44).
  • You are viewing the most recent version of this article.
Copyright & Usage 
Copyright © 2017 by The American Society for Pharmacology and Experimental Therapeutics

Author Information

  1. Amanda M. Maple,
  2. Tanessa Call,
  3. Phylicia C. Kimmel, and
  4. Ronald P. Hammer Jr.
  1. Department of Basic Medical Sciences (A.M.M., P.C.K., R.P.H.), and Departments of Pharmacology and Psychiatry (R.P.H.), University of Arizona College of Medicine, Phoenix; and Department of Psychology (A.M.M., P.C.K., R.P.H.) and Interdisciplinary Graduate Program in Neuroscience (T.C., R.P.H.), Arizona State University, Tempe, Arizona
  1. Address correspondence to:
    Dr. Ronald P. Hammer, Jr., Department of Basic Medical Sciences, University of Arizona College of Medicine- Phoenix, 425 N 5th St., Phoenix, AZ, 85004. E-mail: ron.hammer{at}arizona.edu.
View Full Text

Statistics from Altmetric.com

Article usage

Article usage: February 2017 to January 2023

AbstractFullPdf
Feb 2017142061
Mar 20172033031
Apr 20171022423
May 2017541914
Jun 20171952
Jul 201728610
Aug 201726611
Sep 20173057
Oct 20172322
Nov 20173826
Dec 20171834
Jan 20183552
Feb 20182311
Mar 20188169
Apr 20182185
May 20180213
Jun 20180133
Jul 2018181
Aug 20180157
Sep 201802412
Oct 20181392
Nov 20189129
Dec 201821812
Jan 2019082
Feb 20194158
Mar 201911611
Apr 201911410
May 20190167
Jun 201911916
Jul 201901914
Aug 20190337
Sep 201902311
Oct 201912914
Nov 201913019
Dec 20191178
Jan 20200165
Feb 202001413
Mar 202072714
Apr 20202336
May 2020086
Jun 20200148
Jul 20200118
Aug 20200169
Sep 2020491
Oct 20205137
Nov 20204610
Dec 20206139
Jan 20211149
Feb 2021102412
Mar 202191515
Apr 20214176
May 20216149
Jun 20211117
Jul 2021135
Aug 2021196
Sep 20210133
Oct 202121216
Nov 202131012
Dec 202151110
Jan 202221214
Feb 20223226
Mar 20221196
Apr 202221814
May 202221311
Jun 20224196
Jul 20222155
Aug 202221110
Sep 202221615
Oct 2022077
Nov 202202210
Dec 2022101612
Jan 20234115

PreviousNext
Back to top

In this issue

Journal of Pharmacology and Experimental Therapeutics: 361 (1)
Journal of Pharmacology and Experimental Therapeutics
Vol. 361, Issue 1
1 Apr 2017
  • Table of Contents
  • Table of Contents (PDF)
  • About the Cover
  • Index by author
  • Editorial Board (PDF)
  • Front Matter (PDF)
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for sharing this Journal of Pharmacology and Experimental Therapeutics article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
Effects of Repeated Ropinirole Treatment on Phencyclidine-Induced Hyperlocomotion, Prepulse Inhibition Deficits, and Social Avoidance in Rats
(Your Name) has forwarded a page to you from Journal of Pharmacology and Experimental Therapeutics
(Your Name) thought you would be interested in this article in Journal of Pharmacology and Experimental Therapeutics.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Research ArticleBehavioral Pharmacology

Dopamine Agonist Alleviates PCP-Induced Behaviors

Amanda M. Maple, Tanessa Call, Phylicia C. Kimmel and Ronald P. Hammer
Journal of Pharmacology and Experimental Therapeutics April 1, 2017, 361 (1) 109-114; DOI: https://doi.org/10.1124/jpet.116.238634

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero

Share
Research ArticleBehavioral Pharmacology

Dopamine Agonist Alleviates PCP-Induced Behaviors

Amanda M. Maple, Tanessa Call, Phylicia C. Kimmel and Ronald P. Hammer
Journal of Pharmacology and Experimental Therapeutics April 1, 2017, 361 (1) 109-114; DOI: https://doi.org/10.1124/jpet.116.238634
del.icio.us logo Digg logo Reddit logo Twitter logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Abstract
    • Introduction
    • Materials and Methods
    • Results
    • Discussion
    • Acknowledgments
    • Authorship Contributions
    • Footnotes
    • Abbreviations
    • References
  • Figures & Data
  • Info & Metrics
  • eLetters
  • PDF

Related Articles

Cited By...

More in this TOC Section

  • Role of residues S426 and S430 in cannabinoid tolerance
  • DAT ligands on Cocaine-Food Choice in Monkeys
  • MDPV high-responders to evaluate candidate medications
Show more Behavioral Pharmacology

Similar Articles

Advertisement
  • Home
  • Alerts
Facebook   Twitter   LinkedIn   RSS

Navigate

  • Current Issue
  • Fast Forward by date
  • Fast Forward by section
  • Latest Articles
  • Archive
  • Search for Articles
  • Feedback
  • ASPET

More Information

  • About JPET
  • Editorial Board
  • Instructions to Authors
  • Submit a Manuscript
  • Customized Alerts
  • RSS Feeds
  • Subscriptions
  • Permissions
  • Terms & Conditions of Use

ASPET's Other Journals

  • Drug Metabolism and Disposition
  • Molecular Pharmacology
  • Pharmacological Reviews
  • Pharmacology Research & Perspectives
ISSN 1521-0103 (Online)

Copyright © 2023 by the American Society for Pharmacology and Experimental Therapeutics